D
Nuo Therapeutics, Inc. AURX
$1.63 $0.00460.28% OTC PK
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue 91.94% 106.48% 100.46% 59.78% 208.63%
Total Other Revenue -- -- -- -- --
Total Revenue 91.94% 106.48% 100.46% 59.78% 208.63%
Cost of Revenue 144.10% 139.13% 108.70% 86.80% 218.54%
Gross Profit 80.66% 97.50% 98.26% 51.57% 206.45%
SG&A Expenses 41.78% 24.10% 16.08% -12.42% -13.18%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 49.12% 30.27% 20.61% -7.19% -8.37%
Operating Income -20.30% -5.06% 3.51% 26.87% 37.80%
Income Before Tax -20.29% -5.26% 23.96% 26.87% 38.05%
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations -20.29% -5.26% 23.96% 26.87% 38.05%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -20.29% -5.26% 23.96% 26.87% 38.05%
EBIT -20.30% -5.06% 3.51% 26.87% 37.80%
EBITDA -16.87% -3.44% 4.72% 27.04% 37.97%
EPS Basic -14.88% 0.63% 31.37% 32.45% 42.11%
Normalized Basic EPS -14.47% 0.00% 12.50% 32.48% 41.54%
EPS Diluted -14.88% 0.63% 31.37% 32.45% 42.11%
Normalized Diluted EPS -14.47% 0.00% 12.50% 32.48% 41.54%
Average Basic Shares Outstanding 4.85% 5.82% 10.83% 8.24% 6.84%
Average Diluted Shares Outstanding 4.85% 5.82% 10.83% 8.24% 6.84%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --